Cancelmi Daniel J
Cancelmi Daniel J's purchase track record
Cancelmi Daniel J has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/26/2022 | THC | $474K | +18.9% | +68.5% | +5.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Tenet Healthcare Raises 2026 Outlook, Analysts Lift Targets. Tenet Healthcare recently raised its 2026 financial outlook, prompting analysts like Guggenheim to increase price targets to $307. This positive guidance has driven the stock higher, with the average analyst target now sitting at $285.32. While the company is trading near its 52-week high, questions remain about whether this recent strength is fully reflected in the current valuation.
Transaction History
| ACHC | ▲ Buy | Grant | 6,331 | $0 | 5/6/2026 | View on chart |
| ACHC | ▲ Buy | Grant | 6,625 | $0 | 3/12/2026 | View on chart |
| THC | ▲ Buy | Option Exercise | 33,586 | — | 12/29/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 13,217 | $999K | 12/29/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 14,989 | — | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 71,810 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 5,899 | $350K | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 6,319 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 2,487 | $151K | 3/6/2023 | View on chart |
| THC | ▲ Buy | Option Exercise | 8,673 | — | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 3,413 | $202K | 3/6/2023 | View on chart |
| THC | ▼ Sell | Tax Withholding | 28,264 | $1.7M | 3/6/2023 | View on chart |
| THC | ▲ Buy | Open Market | 11,000 | $474K | 10/26/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 14,988 | — | 2/25/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 5,898 | $506K | 2/25/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 9,044 | — | 2/25/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 3,559 | $305K | 2/25/2022 | View on chart |
| THC | ▲ Buy | Option Exercise | 8,672 | — | 2/24/2022 | View on chart |
| THC | ▼ Sell | Tax Withholding | 3,432 | $279K | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.